“At ATHENA our experience and expertise in technology driven development gives us leverage to build a significant product portfolio comprising commercialized and pipeline products. We do this by selectively collaborating with leading pharmaceutical and biotechnology companies who foster a culture of innovation that keeps us together at the forefront of the field. Our unique capabilities provide opportunities to make a dramatic impact on patients’ lives. We are committed to provide safe, convenient and best quality pharmaceutical products to patients. We develop products in new, advanced areas, by actively engaging with the scientific community, by supporting young scientists and disseminating knowledge to help the increasing number of patients. We have entered into a strategic partnership with one of Premium Company from EUROPE to accelerate development of additional infectious disease products.
With a clear focus on selected markets, we operate in some of the most dynamic countries in ASIA, MENA, Latin America, Central America and Caribbean Islands. The In-depth geographical and market knowledge enables us to adapt to local needs. We are dynamic and open-minded. We seize opportunities and stay strong, even under difficult circumstances.
The spirit and professional approach, which we bring to our business distinguish us among many as a company who aims to surpass currently available treatments”.